Today we kick off our new podcast series, On The Pulse: Talks,
in which we will be exploring the competition law issues associated
with patent settlement agreements. Following the Court of
Justice's judgment in Generics UK
('Paroxetine') last year and in eager anticipation of
its ruling in Lundbeck ('Citalopram')
later this month, we will be examining the current status of the
law and highlighting practical tips for our listeners to be aware
of.
In this first episode, competition law expert Sophie Lawrance introduces the competition law
treatment of patent settlement agreements and so-called
pay-for-delay agreements. Sophie starts by laying the groundwork,
beginning with the definition of patent settlements used in the
European Commission's 2009 Pharmaceutical Sector Enquiry Final
Report, and coming up to date with the most recent case law. (As
with the rest of this series, we will focus on the EU principles,
which at this stage are equally applicable in the